Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Dr. Debu Tripathy
Advertisement
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston.
Articles by Dr. Debu Tripathy
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.
Our longtime editor-in-chief offers advice to his successor while discussing the news and education CURE magazine provides for patients with cancer, families and caregivers.
CURE magazine's outgoing editor-in-chief, Dr. Debu Tripathy, reflects on 18 years of advances in cancer care, the impact of AI and the evolving future of oncology treatment.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.
Advertisement
Latest Updated Articles
We Have Come a Long WayPublished: March 10th 2025 | Updated:
The Role of Circulating Tumor DNA in Breast Cancer MonitoringPublished: March 18th 2025 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Mary’s Place by the Sea Offers Free Retreat and Respite for Women With Cancer
2
Top Breast Cancer Stories to Know as Breast Cancer Awareness Month Kicks Off
3
Besides Oncologists, How Many ‘Gists’ Are There Anyway?
4
What Is CAR-T Cell Therapy’s Role in Pediatric Solid Tumors?
5
